Prinzide vs. Sular: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Prinzide and Sular. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 24,413 people who take Prinzide and Sular, and is updated regularly.
What is Prinzide?
Prinzide has active ingredients of hydrochlorothiazide; lisinopril. It is often used in high blood pressure. eHealthMe is studying from 2,218 Prinzide users. Check the latest studies of Prinzide.
What is Sular?
Sular has active ingredients of nisoldipine. It is often used in high blood pressure. eHealthMe is studying from 1,757 Sular users. Check the latest studies of Sular.
24,413 people who take Prinzide and Sular are studied.

Drugs being compared in this study:
- Prinzide (hydrochlorothiazide; lisinopril)
- Sular (nisoldipine)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Prinzide:
- not at all: 1.25 %
- somewhat: 11.95 %
- moderate: 29.88 %
- high: 41.57 %
- very high: 15.34 %
Sular:
- not at all: 0 %
- somewhat: 11.11 %
- moderate: 37.04 %
- high: 33.33 %
- very high: 18.52 %
Want to compare Prinzide with Sular?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Prinzide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sular:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on hydrochlorothiazide; lisinopril and nisoldipine (the active ingredients of Prinzide and Sular, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Capecitabine cause Paleness? - now
- Drug interactions of Torisel and Lovenox - 3 seconds ago
- Drug interactions of Epclusa and Pepcid - 4 seconds ago
- Could Kisqali cause Dyschezia? - 4 seconds ago
- Could Psyllium Husk cause Dyspnea? - 7 seconds ago
- Could Fasenra cause Lacrimation Increased? - 9 seconds ago
- Drug interactions of Novorapid and Phytonadione - 28 seconds ago
- Could Xywav cause Hypotension? - 29 seconds ago
- Could Tenormin cause Bladder Cancer? - 29 seconds ago
- Could Januvia cause Tardive Dyskinesia? - 42 seconds ago